| 16.04 | Licence to act as a Wholesaler of Medical Devices & IVDs | V1 | | 03-Aug-2017 | 103 KB | |
| 2.04 | Post-importation Testing | V2 | | 20-Jan-2017 | 526 KB | |
| 2.04 | Post-importation testing showing changes | V2 | | 20-Jan-2017 | 509 KB | |
| 2.11 | Safety Reporting during Clinical Trials in South Africa | V2 | | 20-Aug-2016 | 424 KB | |
| 2.40 | Clinical Trial Oversight, Monitoring of Clinical Trials | V1 | | 10-May-2016 | 162 KB | |
| 2.42 | Post Clinical Trial Drug Access | V1 | | 10-May-2016 | 98 KB | |
| 2.45 | Borderline Products | V1 | | 30-Mar-2017 | 795 KB | |
| 2.46 | Co-packaging of Medicines | V1 | | 05-May-2017 | 93 KB | |
| 2.48 | Exemptions from certain medicine registration requirements for Human Medicines – for comment | V1 | | 30-Dec-2017 | 99 KB | |
| 2.49 | Capacity Building and Transformation in Clinical Trials Research in South Africa | V1 | | 10-Mar-2018 | 99 KB | |
| 2.50 | Medicines and Human Reproduction for comment | V1 | | 02-May-2018 | 286 KB | |
| 5.07 | Guideline for recall / withdrawal of Medicines, Medical devices and IVDs – for comment | V4 | | 21-Sep-2015 | 314 KB | |
| 5.07 | Guideline for recall / withdrawal of Medicines, Medical devices and IVDs – showing changes | V4 | | 21-Sep-2015 | 316 KB | |
| 6.1.a | Biological Amendments | V1 | | 19-Jun-2017 | 1 MB | |
| 7.04 | Complementary Medicines – Health Supplements Safety & Efficacy | V3 | | 12-Apr-2017 | 680 KB | |
| 7.04 | Complementary Medicines Health Supplements Safety & Efficacy Annexure J | V3 | 3.1 | 30-May-2017 | 408 KB | |
| 7.06 | Complementary Medicines – Caffeine and Menthol | V1 | | 12-Apr-2017 | 100 KB | |
| 8.01 | General Information – Medical Devices and IVDs for comment | V2 | | 23-Sep-2015 | 807 KB | |
| 8.03 | Conformity Assessment Procedures – Medical Devices and IVDs for comment | V1 | | 23-Sep-2015 | 407 KB | |
| 8.04 | ADR and Post-Marketing Vigilance Reporting of Medical Devices and IVDs for comment | V1 | | 23-Sep-2015 | 165 KB | |